Cardinal Health, Inc. $CAH Shares Bought by Liberty One Investment Management LLC

Liberty One Investment Management LLC increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 8.2% in the 1st quarter, HoldingsChannel reports. The fund owned 166,448 shares of the company’s stock after acquiring an additional 12,569 shares during the period. Cardinal Health accounts for approximately 3.6% of Liberty One Investment Management LLC’s holdings, making the stock its 2nd largest holding. Liberty One Investment Management LLC’s holdings in Cardinal Health were worth $35,172,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after purchasing an additional 617,775 shares during the period. State Street Corp increased its position in shares of Cardinal Health by 1.8% during the 4th quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after purchasing an additional 221,497 shares during the period. Geode Capital Management LLC raised its stake in shares of Cardinal Health by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after buying an additional 43,924 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $790,344,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 2.3%

Shares of Cardinal Health stock opened at $225.54 on Friday. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $243.21. The firm has a market capitalization of $52.82 billion, a PE ratio of 34.49, a price-to-earnings-growth ratio of 1.08 and a beta of 0.49. The stock’s fifty day moving average is $219.32 and its 200-day moving average is $214.34.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts expect that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st were issued a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CAH shares. Robert W. Baird set a $248.00 target price on Cardinal Health in a research note on Friday, May 1st. Wells Fargo & Company dropped their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. JPMorgan Chase & Co. cut their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Bank of America raised their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $250.40.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.